Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could less be more? new trial aims to save lives by using less blood pressure medication in shock

NCT ID NCT05168462

First seen Mar 27, 2026 · Last updated May 22, 2026 · Updated 9 times

Summary

This study looks at whether using less of the drug noradrenaline by aiming for a lower blood pressure (≥55 mmHg) can improve survival and reduce severe kidney failure in people with cardiogenic shock after a heart attack. About 776 adults who have had a heart attack and are in shock will be randomly assigned to either the lower blood pressure target or the standard target (≥65 mmHg). The main goal is to see if the lower target reduces the chance of death or the need for kidney dialysis within 30 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Amsterdam UMC, location AMC

    RECRUITING

    Amsterdam, 1105AZ, Netherlands

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.